Most effective colon cancer chemopreventive agents in rats: A systematic review of aberrant crypt foci and tumor data, ranked by potency

Nutrition and Cancer

Volumn 43, Issue 1, 2002, Pages 1-21

  Corpet, Denis E ^a   Taché, Sylviane ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; AMILORIDE; AZOXYMETHANE; BETA CAROTENE; CANTHAXANTHIN; CELECOXIB; DICLOFENAC; EFLORNITHINE; GENISTEIN; IBUPROFEN; INDOMETACIN; INULIN; MACROGOL; MANGIFERIN; MEVINOLIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PERILLA OIL; PHYTATE; PHYTIC ACID; PIROXICAM; POLOXAMER; QUERCETIN; SULFONIC ACID DERIVATIVE; SULFORAPHANE; SULINDAC; SULINDAC SULFIDE; TETRACYCLINE; UNINDEXED DRUG; ANTINEOPLASTIC AGENT;

CANCER INCIDENCE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CORRELATION ANALYSIS; DIET THERAPY; DRUG EFFICACY; DRUG POTENCY; INTESTINE CRYPT; NONHUMAN; RAT; REVIEW; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON; COLON TUMOR; PATHOLOGY; PRECANCER;

ANIMALIA; PERILLA; RODENTIA;

ANIMALS; ANTICARCINOGENIC AGENTS; COLON; COLONIC NEOPLASMS; PRECANCEROUS CONDITIONS; RATS;

EID: 0036441901     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC431_1     Document Type: Review

References (309)

1. Cummings JH and Bingham SA: Fortnightly review - Diet and the prevention of cancer. Br Med J 317, 1636-1640, 1998.
2. Alberts DS, Martinez ME, Roe DJ, Guillen Rodriguez JM, Marshall JR, et al.: Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 342, 1156-1162, 2000.
3. Bonithon Kopp C, Kronborg O, Giacosa A, Rath U, and Faivre J: Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: A randomised intervention trial. Lancet 356, 1300-1306, 2000.
4. Greenberg ER, Baron JA, Tosteson TD, Ponz de Leon A, and Roncucci L: Antioxidant vitamins and colorectal adenoma. N Engl J Med 331, 1720-1721, 1994.
5. McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, et al.: A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 48, 4701-4705, 1988.
6. McKeown-Eyssen GE, Bright-See E, Bruce WR, Jazmaji V, and Toronto Polyp Prevention Group: A randomized trial of a low-fat highfibre diet in the recurrence of colorectal polyps. J Clin Epidemiol 47, 525-536, 1994.
7. MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P, et al.: Randomized trial of intake of fat, fiber, and β-carotene to prevent colorectal adenomas. JNCI 87, 1760-1766, 1995.
8. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, et al.: Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med 342, 1149-1155, 2000.
9. Baron JA, Beach M, Mandel JS, Vanstolk RU, Haile RW, et al.: Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 340, 101-107, 1999.
10. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342, 1946-1952, 2000.
11. Brasitus TA: Primary chemoprevention strategies for colorectal cancer: Ursodeoxycholic acid and other agents. Gastroenterology 109, 2036-2038, 1995.
12. Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbull BW, et al.: Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 81, 730-734, 1998.
13. Matsuhashi N, Nakajima A, Fukushima Y, Yazaki Y, and Oka T: Effects of sulindac on sporadic colorectal adenomatous polyps. Gut 40, 344-349, 1997.
14. Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, et al.: The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 109, 994-998, 1995.
15. Ponz de Leon M and Roncucci L: Chemoprevention of colorectal tumors: Role of lactulose and of other agents. Scand J Gastroenterol Suppl 222, 72-75, 1997.
16. Bird RP: Observation and quantification of aberrant crypts in murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 37, 147-151, 1987.
17. Bird RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93, 55-71, 1995.
18. Konstantakos AK, Siu IM, Pretlow TG, Stellato TA, and Pretlow TP: Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology 111, 772-777, 1996.
19. Pretlow TP, Siddiki B, Augenlicht LH, Pretlow TG, and Kim YS: Aberrant crypt foci (ACF) - Earliest recognized players or innocent bystanders in colon carcinogenesis. In Colorectal Cancer. Molecular Mechanisms, Premalignant State and Its Prevention, Schmiegel W and Scholmerich J (eds). Dordrecht, The Netherlands: Kluwer Academic, 1999, pp 1-16. (Falk Symp 109)
20. Weisburger JH: Cover legend. Cancer Res 58, 1, 1998.
21. Yamada Y, Yoshimi N, Hirose Y, Matsunaga K, Katayama M, et al.: Sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 61, 1874-1878, 2001.
22. Gold LS, Slone TH, Stem BR, Manley NB, and Ames BN: Rodent carcinogens-setting priorities. Science 258, 261-265, 1992.
23. Pence BC, Budding HF, and Yang SP: Multiple dietary factors in the enhancement of dimethylhydrazine carcinogenesis: Main effect of indole-3-carbinol. JNCI 77, 269-276, 1986.
24. Perdigon G, Valdez JC, and Rachid M: Antitumor activity of yogurt: Study of possible immune mechanisms. J Dairy Res 65, 129-138, 1998.
25. Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, et al.: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program. J Cell Biochem Suppl 20, 32-54, 1994.
26. Baijal PK, Fitzpatrick DW, and Bird RP: Phenobarbital and 3-methylcholanthrene treatment alters phase I and II enzymes and the sensitivity of the rat colon to the carcinogenic activity of azoxymethane. Food Chem Toxicol 35, 789-798, 1997.
27. Wargovich MJ, Jimenez A, McKee K, Steele VE, and Velasco M: Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21, 1149-1155, 2000.
28. Corpet DE, Parnaud G, Delverdier M, Peiffer G, and Tache S: Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens. Cancer Res 60, 3160-3164, 2000.
29. Parnaud G, Tache S, Peiffer G, and Corpet DE: Pluronic F68 block polymer, a very potent suppressor of carcinogenesis in the colon of rats and mice. Br J Cancer 84, 90-93, 2001.
30. Corpet DE and Parnaud G: Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats. Carcino-genesis 20, 915-918, 1999.
31. Komaki C, Okuno M, Onogi N, Moriwaki H, Kawamori T, et al.: Synergistic suppression of azoxymethane-induced foci of colonic aberrant crypts by the combination of β-carotene and perilla oil in rats. Carcinogenesis 17, 1897-1901, 1996.
32. Guo D, Schut HAJ, Davis CD, Snyderwine EG, Bailey GS, et al.: Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 16, 2931-2937, 1995.
33. Parnaud G, Tache S, Peiffer G, and Corpet DE: Polyethylene glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res 59, 5143-5147, 1999.
34. Bak AW, McKnight W, Li P, Del Soldato P, Calignano A, et al.: Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci 62, 367-373, 1998.
35. Rao CV, Desai D, Simi B, Kulkarni N, Amin S, et al.: Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 53, 4182-4188, 1993.
36. Naigamwalla D, Chia MC, Tran TT, Medline A, Hay K, et al.: Polyethylene glycol 8000 and colon carcinogenesis: Inhibition in the F344 rat, promotion in the Min mouse. Cancer Res 60, 6856-6858, 2000.
37. Singletary KW and Medline B: Effect of grape seed proanthocyanidins on colon aberrant crypts and breast tumors in a rat dual-organ tumor model. Nutr Cancer 39, 252-258, 2001.
38. Kohno H, Yoshitani S, Takashima S, Okumura A, Hosokawa M, et al.: Troglitazone, a ligand for peroxisome proliferator-activated receptor-γ, inhibits chemically-induced aberrant crypt foci in rats. Jpn J Cancer Res 92, 396-403, 2001.
39. Liew C, Schut HAJ, Chin SF, Pariza MW, and Dashwood RH: Protection of conjugated linoleic acids against IQ-induced colon carcinogenesis in the F344 rat, a study of inhibitory mechanisms. Carcinogenesis 16, 3037-3043, 1995.
40. Masaoka Y, Katoh O, and Watanabe H: Inhibitory effects of crude salts on the induction and development of colonic aberrant crypt foci in F-344 rats given azoxymethane. Nutr Cancer 37, 78-81, 2000.
41. Onogi N, Okuno M, Komaki C, Moriwaki H, Kawamori T, et al.: Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats. Carcinogenesis 17, 1291-1296, 1996.
42. Rowland IR, Rumney CJ, Coutts JT, and Lievense LC: Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19, 281-285, 1998.
43. Wargovich MJ, Harris C, Chen CD, Palmer C, Steele VE, et al.: Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J Cell Biochem Suppl 16G, 51-54, 1992.
44. Wargovich MJ, Chen CD, Jimenez A, Steele VE, Velasco M, et al.: Aberrant crypts as biomarker for colon cancer: Evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5, 355-360, 1996.
45. Schmelz EM, Bushnev AS, Dillehay DL, Liotta DC, and Merrill AH: Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. Nutr Cancer 28, 81-85, 1997.
46. Fukutake M, Miura N, Yamamoto M, Fukuda K, Iijima O, et al.: Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats. Cancer Lett 157, 9-14, 2000.
47. Schmelz EM, Dillehay DL, Webb SK, Reiter A, Adams J, et al.: Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: Implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 56, 4936-4941, 1996.
48. Mikhailowski R, Shpitz B, Polakcharcon S, Kost Y, Segal C, et al.: Controlled release of TGF-β impedes rat colon carcinogenesis in vivo. Int J Cancer 78, 618-623, 1998.
49. Poulsen M, Molck AM, Thorup I, Breinholt V, and Meyer O: The influence of simple sugars and starch given during pre- or post-initiation on aberrant crypt foci in rat colon. Cancer Lett 167, 135-143, 2001.
50. Ishizuka S and Kasai T: Inhibitory effect of dietary wheat bran on formation of aberrant crypt foci in rat colon induced by a single injection of 1,2-dimethylhydrazine. Biosci Biotechnol Biochem 60, 2084-2085, 1996.
51. Stamp D, Zhang XM, Medline A, Bruce WR, and Archer M: Sucrose enhancement of the early steps of colon carcinogenesis in mice. Carcinogenesis 14, 777-779, 1993.
52. Morishita Y, Yoshimi N, Kawabata K, Matsunaga K, Sugie S, et al.: Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon. Jpn J Cancer Res 88, 815-820, 1997.
53. Takahashi M, Minamoto T, Yamashita N, Yazawa K, Sugimura T, et al.: Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid. Cancer Res 53, 2786-2789, 1993.
54. Tanaka T, Maeda M, Kohno H, Murakami M, Kagami S, et al.: Inhibition of azoxymethane-induced colon carcinogenesis in male F344 rats by the citrus limonoids obacunone and limonin. Carcinogenesis 22, 193-198, 2001.
55. Paulsen JE, Reistad R, Eliassen KA, Sjaastad OV, and Alexander J: Dietary polyamines promote the growth of azoxymethane-induced aberrant crypt foci in rat colon. Carcinogenesis 18, 1871-1875, 1997.
56. Mereto E, Frencia L, and Ghia M: Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett 76, 5-9, 1994.
57. Cassand P, Maziere S, Champ M, Meflah K, Bornet F, et al.: Effects of resistant starch- and vitamin A-supplemented diets on the promotion of precursor lesions of colon cancer in rats. Nutr Cancer 27, 53-59, 1997.
58. Wargovich MJ, Chen CD, Harris C, Yang E, and Velasco M: Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int J Cancer 60, 515-519, 1995.
59. Takahashi M, Totsuka Y, Masuda M, Fukuda K, Oguri A, et al.: Reduction in formation of 2-amino-l-methyl-6-phenylimidazo[4,5b]pyridine (PhIP)-induced aberrant crypt foci in the rat colon by docosahexaenoic acid (DHA). Carcinogenesis 18, 1937-1941, 1997.
60. Nagai T, Ishizuka S, Hara H, and Aoyama Y: Dietary sugar beet fiber prevents the increase in aberrant crypt foci induced by γ-irradiation in the colorectum of rats treated with an immunosuppressant. J Nutr 130, 1682-1687, 2000.
61. Li W, Wanibuchi H, Salim EI, Wei M, Yamamoto S, et al.: Inhibition by ginseng of 1,2-dimethylhydrazine induction of aberrant crypt foci in the rat colon. Nutr Cancer 36, 66-73, 2000.
62. Gali Muhtasib HU, Younes IH, Karchesy JK, and El Sabban ME: Plant tannins inhibit the induction of aberrant crypt foci and colonic tumors by DMH in mice. Nutr Cancer 39, 108-116, 2001.
63. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, et al.: Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18, 957-965, 1997.
64. Kristiansen E, Thorup I, and Meyer O: Influence of different diets on development of DMH-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr Cancer 23, 151-159, 1995.
65. Abdelali H, Cassand P, Soussotte V, Daubeze M, Bouley C, et al.: Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr Cancer 24, 121-132, 1995.
66. Kawamori T, El Bayoumy K, Ji BY, Rodriguez JGR, Rao CV, et al.: Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis. Int J Oncol 13, 29-34, 1998.
67. Schmelz EM, Sullards MC, Dillehay DL, and Merrill AH: Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1,2-dimethylhydrazine-treated CF1 mice. J Nutr 130, 522-527, 2000.
68. Matsunaga K, Iijima H, and Kobayashi H: Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon. Cancer Epidemiol Biomarkers Prev 9, 1313-1322, 2000.
69. Xu M, Bailey AC, Hemaez JF, Taoka CR, Schut HAJ, et al.: Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 17, 1429-1434, 1996.
70. Weisburger JH, Rivenson A, Garr K, and Aliaga C: Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett 114, 323-327, 1997.
71. Matsukawa Y, Nishino H, Okuyama Y, Matsui T, Matsumoto T, et al.: Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons. Oncology 54, 118-121, 1997.
72. Yoshimi N, Qiao Z, Matsunaga K, Mori H, Hanausek M, et al.: The modifying effects of aceglatone, a B-glucuronidase inhibitor, in colon carcinogenesis of F344 rats (abstr). Proc Am Assoc Cancer Res 42, 957, 2001.
73. Zheng Y, Kramer PM, Olson G, Lubet A, Steele VE, et al.: Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Carcinogenesis 18, 2119-2125, 1997.
74. Kawabata K, Tanaka T, Murakami T, Okada T, Murai H, et al.: Dietary prevention of azoxymethane-induced colon carcinogenesis with rice germ in F344 rats. Carcinogenesis 20, 2109-2115, 1999.
75. Rao CV, Simi B, and Reddy BS: Inhibition by dietary curcumin of azoxymethane-induced omithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14, 2219-2225, 1993.
76. Metz N, Lobstein A, Schneider Y, Gosse F, Schleiffer R, et al.: Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr Cancer 38, 60-64, 2000.
77. Rao CV, Kawamori T, Hamid R, and Reddy BS: Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 20, 641-644, 1999.
78. Tanaka T, Kawabata K, Kakumoto M, Makita H, Hara A, et al.: Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis 18, 2155-2161, 1997.
79. Seraj MJ, Umemoto A, Kajikawa A, Mimura S, Kinouchi T, et al.: Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats. Cancer Lett 115, 97-103, 1997.
80. Feng Y, Finley JW, Davis CD, Becker WK, Fretland AJ, et al.: Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2′-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol 157, 36-42, 1999.
81. Kohno H, Yoshitani S, Tsukio Y, Murakami A, Koshimizu K, et al.: Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Life Sci 69, 901-913, 2001.
82. Finley JW, Davis CD, and Feng Y: Selenium from high-selenium broccoli protects rats from colon cancer. J Nutr 130, 2384-2389, 2000.
83. Hatono S, Jimenez A, and Wargovich MJ: Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase. Carcinogenesis 17, 1041-1044, 1996.
84. Dillehay DL, Webb SK, Schmelz EM, and Merrill AH: Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124, 615-620, 1994.
85. Kawamori T, Tanaka T, Kojima T, Suzui M, Ohnishi M, et al.: Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid. Jpn J Cancer Res 85, 686-691, 1994.
86. Zheng Y, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, et al.: Effect of retinoids on AOM-induced colon cancer in rats: Modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 20, 255-260, 1999.
87. Kulkami N and Reddy BS: Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase. Proc Soc Exp Biol Med 207, 278-283, 1994.
88. Avivi Green C, Madar Z, and Schwartz B: Apoptosis-cascade proteins are regulated in vivo by high intracolonic butyrate concentration: Correlation with colon cancer inhibition. Oncol Res 12, 83-95, 2000.
89. Rao CV, Newmark HL, and Reddy BS: Chemopreventive effect of squalene on colon cancer. Carcinogenesis 19, 287-290, 1998.
90. Masaoka Y, Watanabe H, Katoh O, Ito A, and Dohi K: Effects of miso and NaCl on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Nutr Cancer 32, 25-28, 1998.
91. Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, et al.: Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett 155, 79-88, 2000.
92. Davis CD and Feng Y: Dietary copper, manganese and iron affect the formation of aberrant crypts in colon of rats administered 3,2′-dimethyl4-aminobiphenyl. J Nutr 129, 1060-1067, 1999.
93. Narisawa T, Fukaura Y, Hasebe M, Ito M, Aizawa R, et al.: Inhibitory effects of natural carotenoids, α-carotene, β-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett 107, 137-142, 1996.
94. Finley JW, Ip C, Lisk DJ, Davis CD, Hintze KJ, et al.: Cancerprotective properties of high-selenium broccoli. J Agric Food Chem 49, 2679-2683, 2001.
95. Latham P, Lund EK, and Johnson IT: Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 20, 645-650, 1999.
96. Rao CV, Cooma I, Swamy MV, Simi B, and Reddy BS: Modulation of inducible nitric oxide synthase and cyclooxygenase activities by curcumin during different stages of experimental colon carcinogenesis (abstr). Proc Am Assoc Cancer Res 42, 3084, 2001.
97. Rao CV, Hirose Y, Indranie C, and Reddy BS: Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61, 1927-1933, 2001.
98. Challa A, Rao DR, Chawan CB, and Shackelford L: Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 517-521, 1997.
99. Thiagarajan DG, Bennink MR, Bourquin LD, and Kavas FA: Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am J Clin Nutr 68, 1394S-1399S, 1998.
100. Duranton B, Nsiemvo E, Schleiffer R, Gosse F, Galluser M, et al.: Suppression of preneoplastic changes in the intestine of rats fed low levels of polyamines. Cancer Res 57, 573-575, 1997.
101. Pereira MA and Khoury MD: Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett 61, 27-33, 1991.
102. Fukutake M, Yokota S, Kamamura H, Iizuka A, Amagaya S, et al.: Inhibitory effect of Coptidis rhizoma and Scutellariae radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biol Pharmacol Bull 21, 814-817, 1998.
103. Tanaka T, Shimizu M, Kohno H, Yoshitani S, Tsukio Y, et al.: Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci 69, 1935-1945, 2001.
104. Shivapurkar N, Tang ZC, Frost A, and Alabaster O: Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and β-carotene in rats on a high-risk diet. Cancer Lett 91, 125-132, 1995.
105. Perrin P, Pierre F, Patry Y, Champ M, Berreur M, et al.: Only fibres promoting a stable butyrate-producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut 48, 53-61, 2001.
106. Taniyama T, Wanibuchi H, Salim EI, Yano Y, Otani S, et al.: Chemopreventive effect of 24R,25-dihydroxyvitamin D3 in N,N′-dimethylhydrazine-induced rat colon carcinogenesis. Carcinogenesis 21, 173-178, 2000.
107. Koo M and Rao AV: Long-term effect of bifidobacteria and neosugar on precursor lesions of colonic cancer in CF1 mice. Nutr Cancer 16, 249-257, 1991.
108. Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, et al.: Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: The inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res 58, 2550-2556, 1998.
109. Pereira MA, Barnes LH, Rassman VL, Kelloff GV, and Steele VE: Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15, 1049-1054, 1994.
110. Narisawa T, Fukaura Y, Hasebe M, Nomura S, Oshima S, et al.: Prevention of N-methylnitrosourea-induced colon carcinogenesis in rats by oxygenated carotenoid capsanthin and capsanthin-rich paprika juice. Proc Soc Exp Biol Med 224, 116-122, 2000.
111. Charalambous D, Farmer C, and Obrien PE: Sulindac and indomethacin inhibit formation of ACF in the colon of DMH-treated rats. J Gastroenterol Hepatol 11, 88-92, 1996.
112. Suaeyun R, Kinouchi T, Arimochi H, Vinitketkumnuen U, and Ohnishi Y: Inhibitory effects of lemon grass (Cymbopogon citratus Stapf) on formation of azoxymethane-induced DNA adducts and aberrant crypt foci in the rat colon. Carcinogenesis 18, 949-955, 1997.
113. Han BS, Park CB, Takasuka N, Naito A, Sekine K, et al.: A ferulic acid derivative, ethyl 3-(4′-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat. Jpn J Cancer Res 92, 404-409, 2001.
114. Reddy BS, Rao CV, and Seibert K: Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56, 4566-4569, 1996.
115. Smith TK, Lund EK, and Johnson IT: Inhibition of dimethylhydrazine-induced aberrant crypt foci and induction of apoptosis in rat colon following oral administration of the glucosinolate sinigrin. Carcinogenesis 19, 267-273, 1998.
116. Tanaka T, Makita H, Kawamori T, Kawabata K, Mori H, et al.: A xanthine oxidase inhibitor 1′-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 1113-1118, 1997.
117. Jia X and Han C: Effects of green tea on colonic aberrant crypt foci and proliferative indexes in rats. Nutr Cancer 39, 239-243, 2001.
118. Lam LKT and Zhang JL: Reduction of aberrant crypt formation in the colon of CF1 mice by potential chemopreventive agents. Carcinogenesis 12, 2311-2315, 1991.
119. Yoshimi N, Matsunaga K, Katayama M, Yamada Y, Kuno T, et al.: The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats. Cancer Lett 163, 163-170, 2001.
120. Tanaka T, Kohno H, Shimada R, Kagami S, Yamaguchi F, et al.: Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 21, 1183-1189, 2000.
121. Wargovich MJ, Woods C, Liao J, Hollis D, Marquart L, et al.: Calcium-fortified whole grain diet inhibits aberrant crypt foci in the rat colon (abstr). Proc Am Assoc Cancer Res 42, 949, 2001.
122. Rao CV, Chou D, Simi B, Ku HC, and Reddy BS: Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin. Carcinogenesis 19, 1815-1819, 1998.
123. Young GP, McIntyre A, Albert V, Folino M, Muir JG, et al.: Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology 110, 508-514, 1996.
124. Takahashi M, Fukutake M, Isoi T, Fukuda K, Sato H, et al.: Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis 18, 1337-1342, 1997.
125. Yu Z, Xu M, Santanarios G, Shen R, Izquierdopulido M, et al.: A comparison of whole wheat, refined wheat and wheat bran as inhibitors of heterocyclic amines in the Salmonella mutagenicity assay and in the rat colonic aberrant crypt focus assay. Food Chem Toxicol 39, 655-665, 2001.
126. Tsuda H, Park CB, Takasuka N, Baba-Toriyama H, Sekine K, et al.: Influence of ethyl-geranyloxy-methoxyphenyl-propenoate (EGMP) on early stage colon carcinogenesis in rats treated with azoxymethane (AOM). Anticancer Res 19, 3779-3782, 1999.
127. Luceri C, Cademi G, Lancioni L, Aiolli S, Dolara P, et al.: Effects of repeated boluses of sucrose on proliferation and on AOM-induced aberrant crypt foci in rat colon. Nutr Cancer 25, 187-196, 1996.
128. Kim DJ, Kang JS, Ahn B, Kim KS, Park KH, et al.: Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM). Cancer Lett 166, 125-133, 2001.
129. Tanaka T, Kohno H, Yoshitani S, Takashima S, Okumura A, et al.: Ligands for peroxisome proliferator-activated receptors-α and -γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 61, 2424-2428, 2001.
130. Schmelz EM, Bushnev AS, Dillehay DL, Sullards MC, Liotta DC, et al.: Ceramide-β-D-glucuronide: Synthesis, digestion, and suppression of early markers of colon carcinogenesis. Cancer Res 59, 5768-5772, 1999.
131. Paulsen JE, Stamm T, and Alexander J: A fish oil-derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl esters inhibits the formation and growth of aberrant crypt foci in rat colon. Pharmacol Toxicol 82, 28-33, 1998.
132. Kawamori T, Tanaka T, Hara A, Yamahara J, and Mori H: Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res 55, 1277-1282, 1995.
133. Takahashi M, Fukutake M, Yokota S, Ishida K, Wakabayashi K, et al.: Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J Cancer Res Clin Oncol 122, 219-222, 1996.
134. Reddy BS, Hamid R, and Rao CV: Effect of dietary oligofructose and inulin on colonic prerieoplastic aberrant crypt foci inhibition. Carcinogenesis 18, 1371-1374, 1997.
135. Chung FL, Conaway CC, Rao CV, and Reddy BS: Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 21, 2287-2291, 2000.
136. Steele VE, Bagheri D, Balentine DA, Boone CW, Mehta R, et al.: Preclinical efficacy studies of green and black tea extracts. Proc Soc Exp Biol Med 220, 210-212, 1999.
137. Ferguson LR and Harris PJ: Suberized plant cell walls suppress formation of heterocyclic amine-induced aberrant crypts in a rat model. Chem-Biol Interact 114, 191-209, 1998.
138. Harris GK, Carlton PS, Liston BW, Gupta AK, and Stoner GD: Inhibitory effects of freeze-dried black raspberries on AOM-induced colon cancer in the F344 rat (abstr). Proc Am Assoc Cancer Res 42, 948, 2001.
139. Maziere S, Meflah K, Tavan E, Champ M, Narbonne JF, et al.: Effect of resistant starch and/or fat-soluble vitamins A and E on the initiation stage of aberrant crypts in rat colon. Nutr Cancer 31, 168-177, 1998.
140. Challa A, Rao DR, and Reddy BS: Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis 18, 2023-2026, 1997.
141. Tanaka T, Kawamori T, Ohnishi M, Makita H, Mori H, et al.: Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 16, 2957-2963, 1995.
142. Chewonarin T, Kinouchi T, Kataoka K, Arimochi H, Kuwahara T, et al.: Effects of roselle (Hibiscus sabdariffa linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimuriwn and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in F344 rats. Food Chem Toxicol 37, 591601, 1999.
143. Kawamori T, Tanaka T, Hirose Y, Ohnishi M, and Mori H: Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Carcinogenesis 17, 369-372, 1996.
144. Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, et al.: Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice. Cancer Lett 156, 57-61, 2000.
145. Thorup I, Meyer O, and Kristiansen E: Effect of potato starch, cornstarch and sucrose on aberrant crypt foci in rats exposed to azoxymethane. Anticancer Res 15, 2101-2105, 1995.
146. Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, et al.: Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19, 81-85, 1998.
147. Kawamori T, Takahashi M, Watanabe K, Ohta T, Nakatsugi S, et al.: Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor. Cancer Lett 148, 33-37, 2000.
148. Arimochi H, Kinouchi T, Kataoka K, Kuwahara T, and Ohnishi Y: Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem Biophys Res Commun 238, 753-757, 1997.
149. Yoshimi N, Kawabata K, Hara A, Matsunaga K, Yamada Y, et al.: Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. Jpn J Cancer Res 88, 1044-1051, 1997.
150. Jenab M and Thompson LU: The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 19, 1087-1092, 1998.
151. Li H, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, et al.: Effect of calcium on azoxymethane-induced aberrant crypt foci and cell proliferation in the colon of rats. Cancer Lett 124, 39-46, 1998.
152. Gallaher DD and Khil J: The effect of synbiotics on colon carcinogenesis in rats. J Nutr 129, 1483S-1487S, 1999.
153. Agarwal B, Rao CV, Bhendwal S, Ramey WR, Shirin H, et al.: Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology 117, 838-847, 1999.
154. Leleu RK, Young GP, and McIntosh GH: Folate deficiency diminishes the occurrence of aberrant crypt foci in the rat colon but does not alter global DNA methylation status. J Gastroenterol Hepatol 15, 1158-1164, 2000.
155. Salim EI, Wanibuchi H, Taniyama T, Yano Y, Morimura K, et al.: Inhibition of development of N,N′-dimethylhydrazine-induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24R,25-dihydroxyvitamin D3. Jpn J Cancer Res 88, 1052-1062, 1997.
156. 2 expression in colonic tissue. Cancer Lett 134, 129-139, 1998.
157. Morotomi M, Sakaitani Y, Satou M, Takahashi T, Takagi A, et al.: Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats. Nutr Cancer 27, 84-91, 1997.
158. Arimochi H, Kataoka K, Kuwahara T, Nakayama H, Misawa N, et al.: Effects of β-glucuronidase-deficient and lycopene-producing Escherichia coli strains on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem Biophys Res Commun 262, 322-327, 1999.
159. Jenab M and Thompson LU: The influence of flaxseed and lignans on colon carcinogenesis and β-glucuronidase activity. Carcinogenesis 17, 1343-1348, 1996.
160. Pretlow TP, Oriordan MA, Somich GA, Amini SB, and Pretlow TG: Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13, 1509-1512, 1992.
161. Cademi G, Luceri C, Lancioni L, Tessitore L, and Dolara P: Slowrelease pellets of sodium butyrate increase apoptosis in the colon of rats treated with azoxymethane, without affecting aberrant crypt foci and colonic proliferation. Nutr Cancer 30, 175-181, 1998.
162. Baines AT, Holubec H, Basye JL, Thorne P, Bhattacharyya AK, et al.: The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts. Cancer Lett 160, 193-198, 2000.
163. Wijnands MVW, Schoterman HC, Bruijntjes JP, Hollanders VMH, and Woutersen RA: Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats. Carcinogenesis 22, 127-132, 2001.
164. Jain CK, Agarwal S, and Rao AV: The effect of dietary lycopene on bioavailability, tissue distribution, in vivo antioxidant properties and colonic preneoplasia in rats. Nutr Res 19, 1383-1391, 1999.
165. Rijken PJ, Timmer WG, Vandekooij AJ, Vanbenschop IM, Wiseman SA, et al.: Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats. Carcinogenesis 20, 2267-2272, 1999.
166. Kawamori T, Rao CV, Seibert K, and Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58, 409-412, 1998.
167. Reddy BS and Rivenson A: Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res 53, 3914-3918, 1993.
168. St. Clair WH, Billings PC, Carew JA, Keller McGandy C, Newberne PM, et al.: Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res 50, 580-586, 1990.
169. Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, et al.: Chemo-prevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylomithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res 51, 4528-4534, 1991.
170. Kawamori T, Tanaka T, Ohnishi M, Hirose Y, Nakamura Y, et al.: Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats. Cancer Res 55, 4053-4058, 1995.
171. Weed HG, McGandy RB, and Kennedy AR: Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis 6, 1239-1241, 1985.
172. Kim YI, Salomon RN, Graemecook F, Choi SW, Smith DE, et al.: Dietary folate protects against the development of macroscopic colonic neoplasia in a dose-responsive manner in rats. Gut 39, 732-740, 1996.
173. Li H, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, et al.: Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats. Cancer Lett 147, 187-193, 1999.
174. Reddy BS: Dietary fiber and colon cancer: Animal model studies. Prev Med 16, 559-565, 1987.
175. Li H, Schut HAJ, Conran P, Kramer PM, Lubet RA, et al.: Prevention by aspirin and its combination with α-difluoromethylomithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis 20, 425-430, 1999.
176. Mori H, Morishita Y, Shinoda T, and Tanaka T: Preventive effects of magnesium hydroxide on carcinogen-induced large bowel carcinogenesis in rats. Basic Life Sci 61, 111-118, 1993.
177. Disilvestro RA, Greenson JK, and Liao ZM: Effects of low copper intake on dimethylhydrazine-induced colon cancer in rats. Proc Soc Exp Biol Med 201, 94-97, 1992.
178. Dwivedi C, Oredipe OA, Barth RE, Downie AA, and Webb TE: Effects of the experimental chemopreventative agent, glucarate, on intestinal carcinogenesis in rats. Carcinogenesis 10, 1539-1541, 1989.
179. Goldin BR and Gorbach SL: Effect of antibiotics on incidence of rat intestinal tumors induced by 1-2,dimethylhydrazine dihydrochloride. JNCI 67, 877-880, 1981.
180. Reddy BS, Maeura Y, and Weisburger JH: Effect of various levels of dietary butylated hydroxyanisole on methylazoxymethanol acetate-induced colon carcinogenesis in CF1 mice. JNCI 71, 1299-1305, 1983.
181. Reddy BS, Narisawa T, Wright P, Vukusich D, Weisburger JH, et al.: Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 35, 287-290, 1975.
182. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, et al.: Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60, 293-297, 2000.
183. Deschner EE, Ruperto J, Wong G, and Newmark HL: Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12, 1193-1196, 1991.
184. Nutter RL, Gridley DS, Kettering JD, Goude AG, and Slater JM: BALB/c mice fed milk or beef protein: Differences in response to 1,2-dimethylhydrazine carcinogenesis. JNCI 71, 867-874, 1983.
185. Kritchevsky D and Klurfeld DM: Interaction of fiber and energy restriction in experimental colon carcinogenesis. Cancer Lett 114, 51-52, 1997.
186. Hakkak R, Korourian S, Ronis MJ, Johnston JM, and Badger TM: Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats. Cancer Lett 166, 27-32, 2001.
187. Davis AE and Patterson F: Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model. Austr NZ J Med 24, 301-303, 1994.
188. Reddy BS and Maeura Y: Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: Influence of amount and source of dietary fat. JNCI 72, 745-750, 1984.
189. Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, et al.: Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate. Jpn J Cancer Res 88, 821-830, 1997.
190. Rao AV, Goettler DM, and Bird RP: The effect of a low-risk diet on tumor incidence in chemically induced colon cancer in rats. Nutr Cancer 11, 11-20, 1988.
191. Wali RK, Bissonnette M, Khare S, Hart J, Sitrin MD, et al.: 1α,25-dihydroxy-16-ene-23-ene-26,27-hexafluorocholecalciferol, a noncalcemic analogue of vitamin D3, inhibits azoxymethane-induced colonic tumorigenesis. Cancer Res 55, 3050-3054, 1995.
192. Reddy BS, Kawamori T, Lubet RA, Steele VE, Kelloff GJ, et al.: Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res 59, 3387-3391, 1999.
193. Hagiwara A, Miyashita K, Nakanishi T, Sano M, Tamano S, et al.: Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazine. Cancer Lett 171, 17-25, 2001.
194. Furukawa K, Yamamoto I, Tanida N, Tsujiai T, and Nishikawa M: The effects of dietary fiber from Lagenaria scineraria (yugao-melon) on colonic carcinogenesis in mice. Cancer 75, 1508-1515, 1995.
195. Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, et al.: Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 57, 2909-2915, 1997.
196. Craven PA and Derubertis FR: Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis 13, 541-546, 1992.
197. Tanaka T, Kojima T, Suzui M, and Mori H: Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: Suppressing effects on tumor development and biomarkers expression on colon tumorigenesis. Cancer Res 53, 3908-3913, 1993.
198. Earnest DL, Holubec H, Wali RK, Jolley CS, Bissonette M, et al.: Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 54, 5071-5074, 1994.
199. Madar Z, Weiss O, Timar B, Gurevich P, and Zusman I: The effects of high-fiber diets on chemically induced colon cancer in rats. Cancer J 9, 207-211, 1996.
200. Narisawa T, Fukaura Y, Tanida N, Hasebe M, Ito M, et al.: Chemopreventive efficacy of low dose of pravastatin, an HMG-CoA reductase inhibitor, on 1,2-dimethylhydrazine-induced colon carcinogenesis in ICR mice. Tohoku J Exp Med 180, 131-138, 1996.
201. Reddy BS, Tokumo K, Kulkami N, Aligia C, and Kelloff G: Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 13, 1019-1023, 1992.
202. Reddy BS and Marayama H: Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res 46, 3367-3370, 1986.
203. Wilpart M and Roberfroid M: Intestinal carcinogenesis and dietary fibers: The influence of cellulose or Fybogel chronically given after exposure to DMH. Nutr Cancer 10, 39-51, 1987.
204. McIntosh GH, Royle PJ, and Playne MJ: A probiotic strain of Lactobacillus acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutr Cancer 35, 153-159, 1999.
205. Narisawa T, Fukaura Y, Hasebe M, Nomura S, Oshima S, et al.: Prevention of N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn J Cancer Res 89, 1003-1008, 1998.
206. Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I, et al.: Preventive potential of wheat bran fractions against experimental colon carcinogenesis: Implications for human colon cancer prevention. Cancer Res 60, 4792-4797, 2000.
207. Kawamori T, Tanaka T, Suzui M, Okamoto K, Tamai Y, et al.: Chemoprevention of azoxymethane-induced intestinal carcinogenesis by a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats. Carcinogenesis 16, 795-800, 1995.
208. Wattenberg LW: Inhibition of azoxymethane-induced neoplasia of the large bowel by 3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene (nerolidol). Carcinogenesis 12, 151-152, 1991.
209. Tatsuta M, Iishi H, Baba M, Ichii M, Nakaizumi A, et al.: Inhibition by putrescine of experimental carcinogenesis in rat colon induced by azoxymethane. Int J Cancer 47, 738-741, 1991.
210. Sumiyochi H and Wargovich MJ: Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res 50, 5084-5087, 1990.
211. Yoshimi N, Walaszek Z, Mori H, Hanausek M, Szemraj J, et al.: Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. Int J Oncol 16, 43-48, 2000.
212. Corasanti JG, Hobika GH, and Markus G: Interference with dimethylhydrazine induction of colon tumors in mice by E-aminocaproic acid. Science 216, 1020-1021, 1982.
213. Bi S, Geng BQ, and Yong DG: Effects of menadione on 1,2-dimethylhydrazine-induced mouse colon adenocarcinoma. Acta Pharmacol Sin 14, 17-20, 1993.
214. Madar Z, Timar B, Nyska A, and Zusman I: Effects of high-fiber diets on pathological changes in DMH-induced rat colon cancer. Nutr Cancer 20, 87-96, 1993.
215. Ohkami H, Tazawa K, Yamashita I, Shimizu T, Murai K, et al.: Effects of apple pectin on fecal bacterial enzymes in azoxymethane-induced rat colon carcinogenesis. Jpn J Cancer Res 86, 523-529, 1995.
216. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, et al.: Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal antiinflammatory agent. Cancer Res 55, 1464-1472, 1995.
217. Dillehay DL, Webb SK, Schmelz EM, and Merrill AH: Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124, 615-620, 1994.
218. Reddy BS, Rivenson A, Kulkarni N, Upadhyaya P, and El Bayoumy K: Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Res 52, 5635-5640, 1992.
219. Wargovich MJ, Allnutt D, Palmer C, Anaya P, and Stephens LC: Inhibition of the promotional phase of azoxymethane-induced colon carcinogenesis in the F344 rat by calcium lactate: Effect of simulating 2 human nutrient density levels. Cancer Lett 53, 17-25, 1990.
220. Nayini JR, Sugie S, Elbayoumy K, Rao CV, Rigotty J, et al.: Effect of dietary benzylselenocyanate on azoxymethane-induced colon carcinogenesis in male F344 rats. Nutr Cancer 15, 129-139, 1991.
221. Zusman I: Comparative anticancer effects of vaccination and dietary factors on experimentally induced cancers. In Vivo 12, 675-690, 1998.
222. Hughes JS, Ganthavorn C, and Wilsonsanders S: Dry beans inhibit azoxymethane-induced colon carcinogenesis in F344 rats. J Nutr 127, 2328-2333, 1997.
223. Ullah A and Shamsuddin AM: Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 11, 2219-2222, 1990.
224. Narisawa T, Fukaura Y, Yazawa K, Ishikawa C, Isoda Y, et al.: Colon cancer prevention with a small amount of dietary perilla oil high in α-linolenic acid in an animal model. Cancer 73, 2069-2075, 1994.
225. Minoura T, Takata T, Sakaguchi M, Takada H, Yamamura M, et al.: Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Res 48, 4790-4794, 1988.
226. Tatsuta M, Iishi H, Baba M, Uehara H, and Nakaizumi A: Chemoprevention by amiloride of experimental carcinogenesis in rat colon induced by azoxymethane. Carcinogenesis 16, 941-942, 1995.
227. Yamane T, Hagiwara N, Tateishi M, Akachi S, Kim M, et al.: Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn J Cancer Res 82, 1336-1339, 1991.
228. Fukutake M, Nakatsugi S, Isoi T, Takahashi M, Ohta T, et al.: Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis 19, 1939-1942, 1998.
229. Tanaka T, Kohno H, Murakami M, Shimada R, Kagami S, et al.: Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in β-cryptoxanthin and hesperidin. Int J Cancer 88, 146-150, 2000.
230. Reddy BS, Rivenson A, El Bayoumy K, Upadhyaya P, Pittman B, et al.: Chemoprevenfion of colon cancer by organoselenium compounds and impact of high- or low-fat diets. JNCI 89, 506-512, 1997.
231. Goldin BR and Gorbach SL: Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. JNCI 64, 263-265, 1980.
232. Narisawa T, Fukaura Y, Terada K, and Sekiguchi H: Prevention of Nmethylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats. Jpn J Cancer Res 89, 1009-1013, 1998.
233. Zoran DL, Turner ND, Taddeo SS, Chapkin RS, and Lupton JR: Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J Nutr 127, 2217-2225, 1997.
234. Hakkak R, Korourian S, Ronis MJ, Johnston JM, and Badger TM: Dietary whey protein protects against azoxymethane-induced colon tumors in male rats. Cancer Epidemiol Biomarkers Prev 10, 555-558, 2001.
235. Rao CV, Desai D, Rivenson A, Simi B, Amin S, et al.: Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res 55, 2310-2315, 1995.
236. Reddy BS, Rao CV, Rivenson A, and Kelloff G: Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res 53, 3493-3498, 1993.
237. Sinkeldam EJ, Kuper CF, Bosland MC, Hollanders VMH, and Vedder DM: Interactive effects of dietary wheat bran and lard on N-methyl-N′-nitro-N-nitrosoguanidine-induced colon carcinogenesis in rats. Cancer Res 50, 1092-1096, 1990.
238. Karkare MR, Clark TD, and Glauert HP: Effect of dietary calcium on colon carcinogenesis induced by a single injection of 1,2-dimethylhydrazine in rats. J Nutr 121, 568-577, 1991.
239. McIntosh GH, Regester GO, Leleu RK, Royle PJ, and Smithers GW: Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 125, 809-816, 1995.
240. Reddy BS, Sugie S, Maruyama H, and Marra P: Effect of dietary excess of inorganic selenium during initiation and postinitiation phases of colon carcinogenesis in F344 rats. Cancer Res 48, 1777-1780, 1988.
241. Anisimov VN, Zabezhinski MA, Popovich IG, Berstein LM, Kovalenko IG, et al.: Prevention of spontaneous and chemically induced carcinogenesis using activated carbon fiber adsorbent. III. Inhibitory effect of the activated carbon fiber adsorbent "aqualen" on 1,2-dimethylhydrazine-induced intestinal carcinogenesis in rats. Cancer Lett 138, 27-35, 1999.
242. Cademi G, Defilippo C, Luceri C, Salvadori M, Giannini A, et al.: Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 21, 1965-1969, 2000.
243. Rao CV, Rivenson A, Sinai B, and Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55, 259-266, 1995.
244. Holt PR, Mokuolu AO, Distler P, Liu T, and Reddy BS: Regional distribution of carcinogen-induced colonic neoplasia in the rat. Nutr Cancer 25, 129-135, 1996.
245. Rao CV, Rivenson A, Katiwalla M, Kelloff GJ, and Reddy BS: Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res 53, 2502-2506, 1993.
246. Reddy BS, Rao CV, Rivenson A, and Kelloff G: Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14, 1493-1497, 1993.
247. Beaty MM, Lee EY, and Glauert HP: Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high-fat diets. J Nutr 123, 144-152, 1993.
248. Raicht RF, Cohen BI, Fazzini EP, Sarwal AN, and Takahashi M: Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res 40, 403-405, 1980.
249. Lindner MA: A fish oil diet inhibits colon cancer in mice. Nutr Cancer 15, 1-11, 1991.
250. Reddy BS, Sugie S, Maruyama H, El Bayoumy K, and Marra P: Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res 47, 5901-5904, 1987.
251. Reddy BS, Sugie S, and Lowenfels A: Effect of voluntary exercise on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res 48, 7079-7081, 1988.
252. Reddy BS, Narisawa T, and Weisburger JH: Effect of a diet with high levels of protein and fat on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine. JNCI 57, 567-569, 1976.
253. Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma L, et al.: Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res 61, 3647-3652, 2001.
254. Kumar SP, Roy SJ, Tokumo K, and Reddy BS: Effect of different levels of caloric restriction on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res 50, 5761-5766, 1990.
255. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, et al.: Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54, 5841-5847, 1994.
256. Tsukamura M, Goto H, Arisawa T, Hayakawa T, Nakai N, et al.: Dietary maltitol decreases the incidence of 1,2-dimethylhydrazine-induced cecum and proximal colon tumors in rats. J Nutr 128, 536-540, 1998.
257. Tanaka T, Makita H, Ino N, Rahman W, Mori H, et al.: Modifying effects of the arotinoid mofarotene (ro 40-8757) on azoxymethane-induced rat colon and liver carcinogenesis. Cancer J 9, 260-268, 1996.
258. Nyce JW, Magee PN, Hard GC, and Schwartz A: Inhibition of 1,2dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis 5, 57-62, 1984.
259. Penman ID, Elomar E, McGregor JR, Hillan KJ, Odwyer PJ, et al.: Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats. Gut 34, 1559-1565, 1993.
260. Vinas Salas J, Biendicho Palau P, Pinol Felis C, Miguelsanz Garcia S, and Perez Holanda S: Calcium inhibits colon carcinogenesis in an experimental model in the rat. Eur J Cancer 34, 1941-1945, 1998.
261. Anisimov VN, Popovich IG, and Zabezhinski MA: Melatonin and colon carcinogenesis. 1. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 18, 1549-1553, 1997.
262. Tanaka T, Kawabata K, Kakumoto M, Makita H, Ushida J, et al.: Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. Carcinogenesis 20, 1477-1484, 1999.
263. Sekine K, Watanabe E, Nakamura J, Takasuka N, Kim DJ, et al.: Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res 88, 523-526, 1997.
264. Reddy BS and Sugie S: Effect of different levels of ω-3 and ω-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res 48, 6642-6647, 1988.
265. Rijnkels JM, Hollanders VMH, Woutersen RA, Koeman JH, and Alink GM: Interaction of dietary fat and of a vegetables/fruit mixture on 1,2-dimethylhydrazine- or N-methyl-N′-nitro-N-nitrosoguanidineinduced colorectal cancer in rats. Cancer Lett 114, 297-298, 1997.
266. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, et al.: Bifidobacterium longum, a lactic acid-producing intestinal bacterium, inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18, 833-841, 1997.
267. Billings PC, Newbeme PM, and Kennedy AR: Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine. Carcinogenesis 11, 1083-1086, 1990.
268. Thorling EB, Jacobsen NO, and Overvad K: The effect of treadmill exercise on azoxymethane-induced intestinal neoplasia in the male Fischer rat on two different high-fat diets. Nutr Cancer 22, 31-41, 1994.
269. Kawaura A, Takahashi A, Tanida N, Oda M, and Shimoyama T: 1α-hydroxyvitamin D3 suppresses colonic tumorigenesis induced by repetitive intrarectal injection of N-methyl-N-nitrosourea in rats. Cancer Lett 55, 149-152, 1990.
270. Heitman DW, Hardman WE, and Cameron IL: Dietary supplementation with pectin and guar gum on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Carcinogenesis 13, 815-818, 1992.
271. Narisawa T, Fukaura Y, Oshima S, Inakuma T, Yano M, et al.: Chemoprevention by the oxygenated carotenoid β-cryptoxanthin of N-methylnitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res 90, 1061-1065, 1999.
272. Goldin BR, Gualtieri LJ, and Moore RP: The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr Cancer 25, 197-204, 1996.
273. Reddy BS, Wang CX, Samaha H, Lubet P, Steele VE, et al.: Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57, 420-425, 1997.
274. Yamamoto I, Maruyama H, and Moriguchi M: Effect of β-carotene, sodium ascorbate and cellulose on 1,2-dimethylhydrazine-induced intestinal carcinogenesis in rats. Cancer Lett 86, 5-9, 1994.
275. Balansky R, Gyosheva B, Ganchev G, Mircheva Z, Minkova S, et al.: Inhibitory effects of freeze-dried milk fermented by selected Lactobacillus bulgaricus strains on carcinogenesis induced by 1,2-dimethylhydrazine in rats and by diethylnitrosamine in hamsters. Cancer Lett 147, 125-137, 1999.
276. Sugie S, Okamoto K, Rahman KMW, Tanaka T, Kawai K, et al.: Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett 127, 177-183, 1998.
277. McIntosh GH, Royle PJ, and Pointing G: Wheat aleurone flour increases cecal β-glucuronidase activity and butyrate concentration and reduces colon adenoma burden in azoxymethane-treated rats. J Nutr 131, 127-131, 2001.
278. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, et al.: Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59, 597-601, 1999.
279. Seril DN, Liao J, Ho KLK, Yang CS, and Yang GY: Inhibition of chronic ulcerative colitis (UC)-associated carcinogenesis in mice by N-acetyl-L-cysteine (NAC): Effects on oxidative/nitrosative damage and proliferation (abstr). Proc Am Assoc Cancer Res 42, 4647, 2001.
280. Miyagi Y, Om AS, Chee KM, and Bennink MR: Inhibition of azoxymethane-induced colon cancer by orange juice. Nutr Cancer 36, 224-229, 2000.
281. Chang WCL, Chapkin RS, and Lupton JR: Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18, 721-730, 1997.
282. Leleu RK, Young GP, and McIntosh GH: Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 21, 2261-2265, 2000.
283. Pence BC, Dunn DM, Zhao C, Landers M, and Wargovich MJ: Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: Correlation with intermediate endpoints. Carcinogenesis 16, 757-765, 1995.
284. Sugie S, Okamoto K, Okumura A, Tanaka T, and Mori H: Inhibitory effects of benzyl thiocyanate and benzyl isothiocyanate on methylazoxymethanol acetate-induced intestinal carcinogenesis in rats. Carcinogenesis 15, 1555-1560, 1994.
285. Reddy BS, Kawamori T, Lubet R, Steele V, Kelloff G, et al.: Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Carcinogenesis 20, 1645-1648, 1999.
286. Alink GM, Kuiper HA, Hollanders VMH, and Koeman JH: Effect of heat processing and of vegetables and fruit in human diets on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Carcinogenesis 14, 519-524, 1993.
287. Mokady E, Schwartz B, Shany S, and Lamprecht SA: A protective role of dietary vitamin D3 in rat colon carcinogenesis. Nutr Cancer 38, 65-73, 2000.
288. Takahashi T, Satou M, Watanabe N, Sakaitani Y, Takagi A, et al.: Inhibitory effect of microfibril wheat bran on azoxymethane-induced colon carcinogenesis in CF1 mice. Cancer Lett 141, 139-146, 1999.
289. Belleli A, Levy J, Guberman R, and Lamprecht SA: A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis. Carcinogenesis 13, 2293-2298, 1992.
290. Bull A, Bird RP, Bruce WR, Nigro N, and Medline A: Effect of calcium on azoxymethane-induced intestinal tumors in rats (abstr). Gastroenterology 92, 1332, 1987.
291. Samelson SL, Nelson RL, and Nyhus LM: Protective role of faecal pH in experimental colon carcinogenesis. J R Soc Med 78, 230-233, 1985.
292. Cademi G, Luceri C, Defilippo C, Salvadori M, Giannini A, et al.: Slow-release pellets of sodium butyrate do not modify azoxymethane (AOM)-induced intestinal carcinogenesis in F344 rats. Carcinogenesis 22, 525-527, 2001.
293. Cademi G, Giannini A, Lancioni L, Luceri C, Biggeri A, et al.: Characterisation of aberrant crypt foci in carcinogen-treated rats: Association with intestinal carcinogenesis. Br J Cancer 71, 769, 1995.
294. Zhang XM, Stamp D, Minkin S, Medline A, Corpet DE, et al.: Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. JNCI 84, 1026-1030, 1992.
295. Bruce WR, Giacca A, and Medline A: Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9, 1271-1279, 2000.
296. Kelloff GJ, Boone CW, Steele VE, et al.: Mechanistic considerations in the evaluation of chemopreventive data. In Principles of Chemoprevention, Stewart BW, McGregor D, and Kleihues P (eds): Lyon, France: Int Agency Res Cancer, 1996, pp 203-214. (IARC Publ 139)
297. Angres G and Beth M: Effects of dietary constituents on carcinogenesis in different tumor models: An overview from 1975 to 1988. In Cancer and Nutrition, Alfin-Slater RB and Kritchevsky D (eds). New York: Plenum, 1991, pp 337-485.
298. Zhao LP, Kushi LH, Klein RD, and Prentice RL: Quantitative review of studies of dietary fat and rat colon carcinoma. Nutr Cancer 15, 169-177, 1991.
299. Schleiffer R, Duranton B, Gosse F, Bergmann C, and Raul F: Nitric oxide synthase inhibition promotes carcinogen-induced preneoplastic changes in the colon of rats. Nitric Oxide Biol Chem 4, 583-589, 2000.
300. Jacoby RF, Seibert K, Cole CE, Kelloff G, and Lubet RA: The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis. Cancer Res 60, 5040-5044, 2000.
301. Jacoby RF, Cole CE, Lubet RA, and You M: Effect of the nonspecific COX1/2 inhibitor piroxicam and the ornithine decarboxylase inhibitor difluoromethylornithine (DFMO) on development of intestinal tumors in mice bearing germline alteration of the Msh2 or APC gene (abstr). Proc Am Assoc Cancer Res 42, 1422, 2001.
302. Yang K, Fan K, Shinozaki H, Newmark H, Edelmann W, et al.: Sulindac increases carcinoma development in the colons of mice with Apc mutations (abstr). Proc Am Assoc Cancer Res 40, 3488, 1999.
303. Yang K, Fan K, Lia M, Edelmann W, Augenlicht LH, et al.: Sulindac increases tumor development in the colon of mice with Mlh1 +/- mutation (abstr). Proc Am Assoc Cancer Res 42, 1423, 2001.
304. Erdman SH, Ignatenko NA, Powell MB, Blohmmangone KA, Holubec H, et al.: APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis 20, 1709-1713, 1999.
305. 2 gene. J Biol Chem 275, 34013-34016, 2000.
306. Steele VA, Wargovich MJ, Pereira MA, Rao CV, Lubet RA, et al.: Comparison of the azoxymethane AOM-induced rat colon crypt assay with the rat colon tumor assay for cancer chemopreventive agents (abstr). Proc Am Assoc Cancer Res 40, 57, 1999.
307. Carter JW, Lancaster HK, Hardman WE, and Cameron IL: Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res 54, 4304-4307, 1994.
308. Paulsen JE, Namork E, Steffensen IL, Eide TJ, and Alexander J: Identification and quantification of aberrant crypt foci in the colon of Min mice - A murine model of familial adenomatous polyposis. Scand J Gastroenterol 35, 534-539, 2000.
309. Pretlow TP and Bird RP: Correspondence re: Y. Yamada et al. Cancer Res 61, 7699-7700, 2001.